Keynote Speaker: Daniel B. Kopans MD MGH
- Inventor of Digital Breast Tomosynthesis
Experts demonstrate the use of Digital Breast Tomosynthesis (DBT) to reduce call back and increase breast cancer detection. Learn to read DBT studies with a guided interpretation of interesting cases. Contents also include information needed to introduce tomosynthesis to round out the education.
Studio mastered tomosynthesis case presentations include seen only on DBT masses & calcifications, invasive ductal carcinoma, lobular carcinoma, clarification of suspicious regions at screening, impact on call back, workflow case reviews, tomosynthesis warm-up cases, and BI-RADS™ 4/5 cases. This video series includes 40 interesting video case presentations.
Register and start your participation anytime. You control the pace of study. Online/On demand or DVD, participation is fast and efficient. Start when you please, work on at your convenience on your own schedule (start, stop, fast forward, rewind). Print your certificate online.
CME for interpreting physicians:
Earn 8.75 AMA PRA Category I Credits™ in Breast Tomosynthesis CME toward your initial 8 hour training; applies also toward the 15 hour/36 month recurring CME in tomosynthesis for MQSA; see full course catalog if additional hours are needed. ( FDA Reference: 900.12(a)(1)(ii)(C) and 900.12(a)(1)(ii)(B). )
Ensure that your CME and training requirements are documented without the time pressure and commitments of onsite courses.
In addition to DBT CME and DBT training, the program committee recommends that physicians new to DBT participate in hands-on training on DBT workstation (s) prior to independent clinical interpretation.
Digital Breast Tomosynthesis: A Better Mammogram Daniel B. Kopans MD Inventor of Breast Tomosynthesis.
Digital Breast Tomosynthesis with Dr. Ojeda-Fournier Haydee Ojeda-Fournier, MD After a brief overview, Dr. Ojeda-Fournier systematically shares her seasoned experience through examples: detecting cancer, and making such points as reducing callback for cysts and fibroadenomas. She also illustrates limitations to DBT.
Case Reviews: Finding Breast Cancer with 3D Breast Tomosynthesis R. Jared Weinfurtner MD 3D Breast Tomosynthesis: Finding breast cancer, from beginning to end.
Case Reviews: BI-RADS 4 & 5 Finding Breast Cancer with 3D Breast Tomosynthesis R. Jared Weinfurtner MD 3D Breast Tomosynthesis: Finding breast cancer, from beginning to end.
2-D Mammography Synthesized from Tomosynthesis: Strengths, Pitfalls, Artifacts Sona A. Chikarmane, MD In addition to reviewing artifacts on SM versus field digital mammography, Dr. Chikarmane also explores the weaknesses of SM and highlights the strengths.
What is new in BI-RADS 5th Edition Haydee Ojeda-Fournier, MD Dr. Ojeda-Fournier uses clinical images and management tables to teach the precise use of the BI-RADS to improve your patient care.
Breast Tomosynthesis Equipment Options and Quality Control Jerry Thomas MS, FAAPM, DABR, CHP, DABSNM The radiologist is ultimately responsible for the quality of images. What you need to know.
What You Need to Know to Incorporate DBT Into Your Mammography Service Jerry Thomas MS, FAAPM, DABR, CHP, DABSNM The Radiologist’s responsibilities and image quality.
Implementing DBT: Telescope Practical Issues in Starting DBT Shree Lalitha Degala MD Cheryl Wieder RT (M) Community practice implementation experience.
Optional free add on:
The 30-year Effort to Deny Women Access to Mammography Screening Daniel B. Kopans MD Without screening, there is little reason to image the breast. Tomosynthesis and other improvements depend on appropriate screening. Dr. Kopans presents the evidence you need to know for the American Cancer Society and ACR screening mammography recommendations, compared with controversial new guidelines that may restrict mammography, the only test for breast cancer that is proven to save lives in randomized controlled trials.
Efficiency Learning Systems, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Efficiency Learning Systems, Inc. designates this enduring material for a maximum of
8.75 AMA PRA Category 1 Credits™ withSA-CME forMOC.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Expert opinion and guidance is needed in evolution of Multi-Modality breast imaging, breast care practice, and breast imaging technology.
Review the required information: target audience, learning objectives and disclosure information.
Complete the entire activity.
Successfully pass the post test with a minimum score of 80%.
Complete the evaluation and claim your certificate. *Note: When participants successfully pass the test, ELS will send the Claim Credit Instructions
This course has been designed for Physicians, Radiologists, and other licensed health care providers who participate in breast care or imaging.
Upon completion of this activity, participants should be able to:
Practice using personalized breast imaging examination reports that comply with BI-RADS™ structure to facilitate communication among the breast care team, scalable multi-center research, and individual outcomes assessment.
Access the results of new breast care-imaging research and assess their potential applications to clinical practice.
Appraise the potential of tomosynthesis innovations and advances to enhance clinical practice and problem solving.
Describe knowledge and skills relevant to clinical practice of breast care-imaging.
Apply principles of critical thinking to screening recommendations from experts and peers in the radiological sciences, and other members of the breast care team.
FDA Notes and Resources:
"Interpreting Physician New Mammographic Modality Training
Citation: 900.12(a)(1)(ii)(C): Before an interpreting physician may begin independently interpreting mammograms produced by a new mammographic modality, that is, a mammographic modality in which the physician has not previously been trained, the interpreting physician shall have at least 8 hours of training in the new mammographic modality."
900.12(a)(1)(ii)(B) "(ii) Continuing experience and education. All interpreting physicians shall maintain their qualifications by meeting the following requirements:.....(B)...15 category I continuing medical education units in mammography during the 36 months immediately preceding the date of the facility's annual MQSA inspection.....This training shall include at least six category I continuing medical education credits in each mammographic modality used by the interpreting physician in his or her practice......"
Efficiency Learning Systems endorses the standards of the ACCME, ANCC, and ACPE that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.
A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which, therefore, may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
Efficiency Learning Systems will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Efficiency Learning Systems does not endorse any products or services.
Relevant financial relationships exist between the following individuals and commercial interests:
Faculty, planning committee, and others in position to affect teaching content of this activity have no relevant financial relationships to disclose.Disclosures are on file.There is no commercial support for this activity. Efficiency Learning Systems, Inc. provided editorial and production support to the program committee, which, with faculty, is responsible for course content.
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
Unapproved Use Disclosure
Efficiency Learning Systems requires CME faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may/will discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Privacy & Information
Efficiency Learning Systems is an Equal Opportunity/ Equal Access/ Affirmative Action Institution.
Cancellation / Refund Policy
Efficiency Learning Systems reserve the right to cancel this activity due to unforeseen circumstances: registrants will receive refund of tuition charge paid as full liquidated damages.The Efficiency Learning Systems Inc. (ELS) policy since 1995 is: Satisfaction guaranteed. The tuition charge paid by a participant will be refunded upon request.You always receive the latest edition of any program, and automatically benefit from any enhancements that occur while you are participating in online offerings.